MET and breast cancer: Hence, we define TGFβ1 as a regulator of MET expression in breast cancer by upregulating C‐ets‐1 and downregulating miR‐128‐3p expression, which results in cell migration, invasion, and metastasis in a HGF‐dependent manner (Fig. 7).